Remove 2028 Remove Documentation Remove Drug Development
article thumbnail

Understanding Large Molecule Drug Development: From Biologics to Market

Syner-G

Cell Line Development Demand for biologics has impacted the cell line development (CLD) market, expected to reach $1.7 billion by 2028. This documentation supports process control, and optimization, and serves as a regulatory record of reliability and repeatability.

article thumbnail

Can your LNP manufacturing platform cope with the pace of the mRNA revolution?

Pharmaceutical Technology

Genomic medicine development was ranked as the top industry trend for 2023 in a survey of 198 GlobalData Pharma clients and prospects conducted between October and November 2022. billion by 2028. Regulatory documentation including a materials traceability report is provided and an extractables report is available upon request.